FilingIndex
6-KThe Wire

GSK plc files 6-K

Filed Apr 29, 2026 · 2mo ago · Accession 0001654954-26-004051

Plain English

GSK plc reported total operating profit of £2,293 million for Q1 2026, an increase of 9% at constant exchange rates (CER) compared to Q1 2025. This performance was driven by strong Specialty Medicines sales and core operating profit growth, partly offset by higher contingent consideration liabilities (CCL) charges.

Read the original on SEC.gov ↗
Filing details
Company
GSK plc
Ticker
GSK
CIK
1131399
Form type
6-K
Filing date
Apr 29, 2026
Report date
Apr 29, 2026
Document
a2755c.htm
Size
1.5 MB
GSK 6-K (Apr 29, 2026) — FilingIndex